Drug Profile
Recombinant human serum albumin-interferon alpha fusion protein - Hangzhou Jiuyuan Gene Engineering
Alternative Names: rHSA-IFNα2bLatest Information Update: 19 Feb 2016
Price :
$50
*
At a glance
- Originator Hangzhou Jiuyuan Gene Engineering
- Class Recombinant fusion proteins
- Mechanism of Action Immunostimulants; Interferon alpha 2b stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Hepatitis B; Hepatitis C
Most Recent Events
- 18 Feb 2016 Investigation in Hepatitis B in China (Parenteral)
- 18 Feb 2016 Investigation in Hepatitis C in China (Parenteral)